Several years of extra strict rules for collaborations with healthcare professionals have made it difficult for Glaxosmithkline to communicate its message. The company therefore reduces its demands in different countries, including Denmark, and will again allow doctors to receive payment for certain tasks.
Log in to read our articles
Welcome to MedWatch. A part of our content is exclusive and reserved for our users.